|
Jan 5
|
Private equity firms are HUTCHMED (China) Limited's (LON:HCM) biggest owners and were rewarded after market cap rose by UK£120m last week
|
|
Jan 2
|
Hutchmed divests 45% interest in Shanghai Hutchison for $608M
|
|
Jan 2
|
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Patients with MET amplification After Progression on First-Line EGFR Inhibitor Therapy
|
|
Jan 1
|
HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture
|